James Molecular Laboratory, The Ohio State University Wexner Medical Center, Columbus, Ohio.
James Molecular Laboratory, The Ohio State University Wexner Medical Center, Columbus, Ohio; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
J Mol Diagn. 2024 Feb;26(2):140-149. doi: 10.1016/j.jmoldx.2023.11.004. Epub 2023 Nov 24.
Detection of cancer-associated gene fusions is crucial for diagnosis, prognosis, and treatment selection. Many bioinformatics tools are available for the detection of fusion transcripts by RNA sequencing, but there are fewer well-validated software tools for DNA next-generation sequencing (NGS). A 542-gene solid tumor NGS panel was designed, with exonic probes supplemented with intronic bait probes against genes commonly involved in oncogenic fusions, with a focus on lung cancer. Three software tools for the detecting gene fusions in this DNA-NGS panel were selected and evaluated. The performance of these tools was compared after a pilot study, and each was configured for optimal batch analysis and detection rate. A blacklist for filtering common tool-specific artifacts, and criteria for selecting clinically reportable fusions, were established. Visualization tools for annotating and confirming somatic fusions were applied. Subsequently, a full clinical validation was used for comparing the results to those from in situ hybridization and/or RNA sequencing. With JuLI, Factera, and GeneFuse, 94.1%, 88.2%, and 66.7% of expected fusions were detected, respectively. With a combinatorial pipeline (termed FindDNAFusion), developed by integrating fusion-calling tools with methods for fusion filtering, annotating, and flagging reportable calls, the accuracy of detection of intron-tiled genes was improved to 98.0%. FindDNAFusion is an accurate and efficient tool in detecting somatic fusions in DNA-NGS panels with intron-tiled bait probes when RNA is unavailable.
检测癌症相关基因融合对于诊断、预后和治疗选择至关重要。有许多生物信息学工具可用于通过 RNA 测序检测融合转录本,但用于 DNA 下一代测序 (NGS) 的经过充分验证的软件工具较少。设计了一个包含 542 个基因的固体肿瘤 NGS 面板,外显子探针辅以针对常见致癌融合基因的内含子诱饵探针,重点是肺癌。选择并评估了用于检测该 DNA-NGS 面板中基因融合的三种软件工具。在试点研究后比较了这些工具的性能,并为每个工具配置了最佳的批量分析和检测率。建立了一个黑名单用于过滤常见的工具特定伪影,并建立了选择有临床报告价值的融合的标准。应用了注释和确认体细胞融合的可视化工具。随后,使用全临床验证将结果与原位杂交和/或 RNA 测序的结果进行比较。使用 JuLI、Factera 和 GeneFuse,分别检测到了 94.1%、88.2%和 66.7%的预期融合。通过将融合调用工具与融合过滤、注释和标记有报告价值的调用的方法相结合,开发了一种名为 FindDNAFusion 的组合管道,提高了内含子平铺诱饵探针的基因检测的准确性,达到了 98.0%。当 RNA 不可用时,FindDNAFusion 是一种在含有内含子平铺诱饵探针的 DNA-NGS 面板中检测体细胞融合的准确且高效的工具。